Daxor Announces That The United States Patent And Trademark Office Has Issued The Company A Second Patent, Safeguarding A Distinctive Clinical Guidance System For Blood Volume Management
Portfolio Pulse from Benzinga Newsdesk
Daxor Corporation has been granted a second patent by the United States Patent and Trademark Office for a clinical guidance system for blood volume management. This system uses unique blood volume metrics and related clinical measures to assist in fluid management interventions.
January 09, 2024 | 1:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Daxor Corporation has received a new patent for its blood volume management system, which could strengthen its market position and potentially lead to increased adoption of its technology.
The issuance of a second patent for Daxor's clinical guidance system is a positive development for the company, likely providing a competitive advantage and intellectual property protection. This could result in increased investor confidence and potential market expansion for their technology, positively impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100